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Prostagiandin E 2 (PGE 2 ) is found in the rat brain (Abdel-Halim et al. 1977) , but its possible physio10gical functions in the central nervous system are not known. Some investigators have suggested that prostaglandins may be involved in the central control of the cardiovascular and thermoregulatory systems (Coceani 1974 , Karppanen et al. 1979 . PGE 2 raised the blood pressure and heart rate of conscious rats upon intracerebroventricular (i.c. v.) administration (Hoffman & Schmid 1979) . Prostaglandins of the E-series are also highly active hyperthermic agents in the brain (Milton 1976 , Splawinski et al. 1978 . However, the possible association between the cardiovascular and thermal effects of centrally administered PGE 2 has not been studied.
In the present study increasing doses of PGE 2 were administered intravenously (i. v.) or i.c. v. to the urethaneanesthetised rat in order to obtain complete simultaneous cumulatative dose-response curves for blood pressure, heart rate and body temperature. Since sodium meclofenamate interferes with the actions of exogenous prostaglandins both in the peripheral tissues (Bennett et al. 1980a, b) and in the brain (Karppanen et al. 1979 , it seemed worthwhile to examine the influence of this agent on the central effects of PGE 2 • For comparison, the effects of indomethacin, an equally effective inhibitor of prostagiandin synthesis as sodium meclofenamate (Flower 1974) , were also studied .
MATERIALS AND METHODS
Male Wistar rats (260-360 g) were used . The rats were accommodated to standard ambient conditions for at least one week before the experiments. The lights were on from 6 a.m. to 6 p.m. and the room was completely dark during the remaining 12 h. The temperature was kept at 22°C and the relative humidity at 40 %. The rats received standard rat pellets (Hankkija Oy, Helsinki) and tap water ad libiturn.
The rats were anesthetised with urethane (1 .5 g/kg intraperitoneally). The trachea was cannulated with a poly-I A preliminary report of this work has been presented at the XXXII Meeting of the Scandinavian Pharmacological Sl.ciety (Sin~n 1981 a) . heating lamp was placed 20 cm above the rat. Experiments on control rats showed that this distance of the heating lamp was adequate to keep the body temperature at 36.9±0.3°C (mean ±SE) in an ambient temperature of 2rC .
Administration 01 drugs
Prostagiandin E 2 (PGE 2 ), kindly supplied by Dr J. Pike of the Upjohn Laboratories , was dissolved in absolute ethanol (10 mg/mI) and stored at -20°C. Further dilutions were made freshly each day in 0.9% (w/v) NaCI (saline) for i.v. injections, and in a modified Krebs-Ringer bicarbonate buffer (see Karppanen et al. 1979 ) for i.c.v. injections . These were given in a volume of 10 /1-1 each and the i.v. injections in a volume of 0.15 ml each. The control animals received the same volume of the vehicle (buffer or saline solution with the corresponding concentration of ethanol as in the drug solution) in each case. Increasing doses of PGE 2 were administered i.c.v. at 20 min intervals in order to obtain cumulative dose-response curves. This interval was chosen because in the preliminary experiments (PGE 2 administered at 45 min intervals) the maximum cardiovascular effects of PGE were reached within 15-20 min after each i.c.v. injection. For comparison, the i.v. injections were also repeated at 20 min intervals to make sure that the effects induced by centrally administered PGE 2 were not due to a leakage of the drug into the peripheral circulation. Indomethacin (Orion Pharmaceutical Co., Helsinki) was dissolved in 0.25 N NaOH and sodium meclofenamate monohydrate (Parke , Davis & Co.) in saline. The influence of central pretreatment with indomethacin or sodium meclofenamate on the central effects of PGE 2 was studied by injecting these drugs i.c.v. at a dose of I mg/rat 20 min before commencement of the administrations of increasing doses of PGE 2 i.c.v. The control animals received the same volume of saline or NaOH in each case.
The Student's t-test was used to calculate the statistical significance of the differences between the control and experimental groups.
RESULTS

I. Effects of prostagIandin E 2 in non-pretreated rats
Effect of PGE 2 on blood pressure (Fig. 1) . Intracerebronventricular administration of PGE 2 at the doses of 0.001-10 p,g/rat raised the blood pressure.
The maximum pressor effect was reached 15 to 20 min after each injection. At the highest dose of 10 p,g/rat PGE 2 i.c.v. induced an initial hypotensive effet which had its maximum 1-2 min after the injection. The initial hypotension was followed by a longer lasting hypertensive phase . Intravenously , PGE 2 (0.01-10 p,g/rat) induced a biphasic blood pressure response with a strong dose-related initial decrease followed by a slight increase in blood pressure. The maximum hypotensive effeet was aehieved 1-2 min after eaeh i.v. injeetion. Effect of PGE 2 on heart rate (Fig. 2) . PGE 2 indueed a substantial taehyeardie effeet, when administered at the doses ofO.OO1-l0,ug/rat i.e.v. The maximum inerease in heart rate was reaehed 1(}"'20 min after eaeh injeetion . I.v. PGE 2 at the same doses slightly inereased the heart rate. In addition , at the highest i.v. dose PGE 2 eaused a transient initial deerease in heart rate .
Effect of PGE 2 on body temperature (Fig. 3) . PGE 2 at the i.e.v. doses ofO.OOl-lO,ug/rat indueed a strong hyperthermie efIeet. The maximum efIeet, about 2SC , was reaehed with the highest dose. I.v. the same doses ofPGE 2 only slightly raised the body temperature. 
EfJects ofindomethacin and sodium meclofenamate
Centrally administered indomethaein (1 mg/rat i.e. v.) indueed a slight but statistieally signifieant inerease in heart rate (about 20 beats/rn in) but had no signifieant efIeet on blood pressure or body temperature. The same dose of sodium meclofenamate had no signifieant efIeet on blood pressure, heart rate or body temperature (see legend of Fig.   4 ) . (Fig. 4) . Central pretreatment with indomethacin (1 mg/rat i.e. v.) partly antagonised the eentral hypertensive, taehyeardic and hyperthermie effeets of PGE 2 • EfJects of sodium meclofenamate pretreatment (Fig. 4) . Central pretreatment with sodium meclo- 4 . Effect of i.c.v . administered PGE 2 on blood pressure, heart rate and body temperature in indomethacin or sodium mec10fenamate pretreated rats . Indomethacin, I mg/rat (.A-A), sodium mec1ofenamate, I mg/rat (e-e) or vechic1e (0--0) was administered i.c .v. 20 min before commencement of the administration of PGE 2 • lncreasing doses of PGE 2 were administered i.c.v. at 20 min intervals. The maximum changes 15-20 min after each injection are shown. The initial blood pressure, heart rate and body temperature levels (means±SE) were 113±8 mmHg, 460± 10 beatsImin and 36.5±0.2°C in the control group, 115±8 mmHg, 480± 10 beatsImin and 36.9±0.3°C in the indomethacin pretreated group and 112±3 mmHg, 470± 10 beatsImin and 36.4±0.3°C in the sodium mec10fenamate pretreated group. The difference between the initial heart rate values of the indomethacin group and control group is significant at the p<0.05 level. Vertical bars indicate SE. Control and indomethacin pretreated group comprised 6 rats and sodium mec10fenamate pretreated group 5 rats, except for the PGE 2 doses of 1 a~d 10 Jlg/rat in experimental groups (4 rats) . * p<0.05 , ** p<0.OO5 and *** p<O.OOl vs. control group.
EfJects of prostaglandin E 2 in indomethacin or sodium meclofenamate pretreated rats Effect of indomethacin pretreatment
fenamate (1 mg/rat i.c. v.) wholly abolished the hypertensive effect of i.c. v. administered PGE 2 • The tachycardic response to PGE 2 i.c.v. was also partly antagonised by sodium meclofenamate , while the
PGErinduced central hyperthermia was not significantly influenced by sodium meclofenamate.
DISCUSSION
Intracerebroventricular administration of PGE 2 at the doses of 0.001-10 #g/rat raised the blood pressure, heart rate and body temperature of the urethane-anesthetised rat. At the highest dose PGE 2 caused a brief initial decrease in blood pressure. Since the same doses initially strongly decreased and subsequently slightly increased the blood pressure upon i.v. administrations, the PGErinduced rises of blood pressure, heart rate · and body temperature were due to an action of the drug upon the central nervous system rather than to a leakage into the peripheral circulation. In addition , PGE 2 i.v. had only negligible effects on body temperature and heart rate. Moreover, the antagonism of the central effects of PGE 2 by i.c. v. pretreatment with indomethacin or sodium meclofenamate further supports the suggestion that the effects of i.c. v. administered PGE 2 are due to an action on the cerebral structures. However, the brief initial hypotensive effect of the highest i.c.v. dose of PGE 2 was not significantly antagonised by centrally administered indomethacin or sodium meclofenamate. Since prostaglandins are known to cross the blood-brain baITier (Holmes & Horton 1968) , the possibility cannot be excluded that, at least the hypotensive effect of i.c. v. administered PGE 2 , might be due to a partial leakage of the drug into the periphery.
In agreement with the present results the i.c.v. administration of PGE 2 at the doses of 0.05-5000 ng/rat raised the blood press ure and heart rate of conscious rats (Hoffman & Schmid 1979) . The hyperthermie effect of centrally administered PGE 2 has been previously demonstrated in many mammalians , including the rat (Milton 1976 , Splawinski et al. 1978 . The rises of blood pressure and heart rate after the administration of the smallest dose of PGE 2 became apparent earlier than did the increase in body temperature. It can thus be concluded that the cardiovascular changes were not a consequence of the hyperthermia. However, the dose-response curve for the hyperthermie effect ofPGE 2 lies within about the same dose range as that for the cardiovascular changes so that it cannot be argued that PGE 2 is more selective in inducing cardiovascular changes than a rise of the body temperature.
The central effects of PGE 2 were similar to those of PGF 2a or the prostagiandin precursor, arachidonic acid (Karppanen et al. 1979 , Sin!n 1982 . PGE 2 and PGF 2a are both endogenously formed by the rat brain (Abel-Halim et al. 1977) . Therefore the formation of PGE 2 and/or PGF 2a from arachidonic acid in the brain rnight, under some physiological or pathophysiological conditions, contribute to the central control of the cardiovascular and thermoregulatory systems.
Sodium meclofenamate completely abolished the hypertensive effect but did not significantly affect the other effects of centraUy administered PGE 2 • Indomethacin only partly inhibited the hypertensive effect of PGE 2 but unlike sodium meclofenamate this drug was able to reduce all the centrallyinduced responses to PGE 2 • In agreement with the present results sodium meclofenamate proved to be more potent in inhibiting the hypertensive than the tachycardic or hyperthermic effects of arachidonic acid (Siren 1982) , while indomethacin affected equally the cardiovascular and thermal responses to i.c.v. administered arachidonic acid (Siren & Karppanen 1981) . Furthermore, the central hypotensive effect of prostacyclin was antagonised by central pretreatment with sodium meclofenamate but not with indomethacin (Siren 1981 b) . Hence the present findings lend further support to our previous suggestion (Karppanen et al. 1979 ) that there might be differences in the modes and/or sites of action between sodium meclofenamate and indomethacin.
The mechanism by wh ich indomethacin and sodium meclofenamate inhibit the responses to centrally administered prostaglandins is not known. However, in agreement with the present results an antagonism of the effects of exogenous prostaglandins by indomethacin and fenamates has also been reported in the alimentary muscle of the guinea-pig and rat (Bennett et al. 1980a , b, Lembeck & Juan 1974 . The blockade of prostagiandin receptors by indomethacin and sodium meclofenamate might explain the inhibition of the effects of exogenous prostaglandins by these drugs. However, both indomethacin and fenamates effectively inhibit the synthesis of prostaglandins (Flower 1974) . Due to the decreased synthesis of endogenous prostaglandins the total amount of these agents, endogenous plus exogenous, present at the receptors after the administration of exogenous prostaglandins, may be decreased. This might explain, at least partly, the Ceneral effects 0/ prostagiandin E2 233 dirninished effects of prostaglandins after the treatment with the inhibitors of prostagiandin synthesis . Therefore the effects of indomethacin and sodium meclofenamate might be due to both the inhibition of the endogenous synthesis of prostaglandins and the blockade of prostagiandin receptors.
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